History of Development
The VACUMED ® -device is based on medical and technical requirements of manned space missions, which takes place in zero gravity. Zero gravity leads to orthostatic complications for astronauts which would make manned space missions impossible. The solution to this problem was developed in the sixties at the Institute for Aerospace Medicine of the German Aerospace Association (DLR) in Cologne. The result is the so-called LBNPD (Lower Body Negative Pressure Device). The physiological principle is impinging the lower body with permanent negative pressure. This leads to a desired capillary dilatation and hence, prevents the orthostatic complications.
Cf.
(http://nssdc.gsfc.nasa.gov/nmc/experimentDisplay.do?id=1973-027A-51
Esch BT et al., 2007).
In 1999 the development of the intermittent variant of the LBNPD began as a Neurolab project.
Continue
The goal:
Research partner of the DLR and patent rights:
Weyergans High Care AG, Dueren, Germany
Commercial device:
VACUMED ®
Application:
continue
- Cardiovascular stimulation
- Improvement in blood circulation
- Improvement of the venous-lymphatic reflux in vascular diseases
Research partner of the DLR and patent rights:
Weyergans High Care AG, Dueren, Germany
Commercial device:
VACUMED ®
Application:
- Treatment and prophylaxis of circulatory disorders
- Use in the rehabilitation
continue
